Compare TEX & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEX | SHC |
|---|---|---|
| Founded | 1933 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3B | 4.4B |
| IPO Year | 1994 | 2020 |
| Metric | TEX | SHC |
|---|---|---|
| Price | $60.42 | $15.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $68.80 | $20.33 |
| AVG Volume (30 Days) | 1.0M | ★ 3.5M |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | N/A | ★ 0.09 |
| Revenue | ★ $5,421,000,000.00 | $1,163,617,000.00 |
| Revenue This Year | $47.67 | $7.51 |
| Revenue Next Year | $6.66 | $6.00 |
| P/E Ratio | ★ N/A | $173.00 |
| Revenue Growth | 5.73 | ★ 5.74 |
| 52 Week Low | $41.70 | $10.80 |
| 52 Week High | $71.50 | $19.85 |
| Indicator | TEX | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 48.92 | 50.86 |
| Support Level | $58.36 | $15.16 |
| Resistance Level | $62.24 | $16.41 |
| Average True Range (ATR) | 2.28 | 0.45 |
| MACD | 0.34 | -0.02 |
| Stochastic Oscillator | 62.19 | 57.63 |
Terex is a global manufacturer of aerial work platforms, materials processing equipment, and specialty equipment for the waste, recycling, and utility industries. Its current composition is a result of numerous acquisitions over several decades to focus on a smaller group of light construction and other vocational equipment, having divested a handful of underperforming businesses, particularly in cranes and other lifting equipment. These remaining segments see heavy demand in nonresidential construction (aerial work platforms—40% sales), aggregates/mining (materials processing—30% sales), environmental, waste/recycling and utilities (environmental solutions group—30% sales).
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.